← Back to headlines
Regeneron's Otarmeni Application Accepted for EMA Review
Regeneron (REGN) has announced that the European Medicines Agency (EMA) has accepted its application for Otarmeni for review.
31 May, 08:23 — 31 May, 08:23
Sources
Showing 1 of 1 sources
Related Stories
Warsh’s Jackson Hole Address Signals Potential Rate Hikes Amid Inflation Fears
22m ago
India Proposes Mandatory Front-of-Pack Warnings for Unhealthy Foods
37m ago
Widespread Russian Drone Strikes Hit Ukrainian Infrastructure and Civilian Areas
44m ago
India’s Foreign Exchange Reserves Hit Record High of $729 Billion
1h ago